TWO SIGMA ADVISERS, LP - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 141 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$683,274
-43.8%
259,800
-24.6%
0.00%
-33.3%
Q2 2023$1,216,438
+3.4%
344,600
-9.5%
0.00%0.0%
Q1 2023$1,176,054
+1.0%
380,600
+38.2%
0.00%0.0%
Q4 2022$1,164,942
+163.6%
275,400
+47.6%
0.00%
+200.0%
Q3 2022$442,000
+10.0%
186,600
+32.3%
0.00%0.0%
Q2 2022$402,000
+51.1%
141,000
+52.9%
0.00%0.0%
Q1 2022$266,000
+65.2%
92,200
+74.0%
0.00%
Q4 2021$161,000
-89.3%
53,000
-75.3%
0.00%
-100.0%
Q3 2021$1,502,000
+14.0%
214,200
+49.2%
0.00%
+33.3%
Q2 2021$1,318,000
+114.0%
143,600
+126.5%
0.00%
+50.0%
Q1 2021$616,000
-71.5%
63,400
-69.4%
0.00%
-66.7%
Q2 2020$2,162,000
+12.7%
207,300
-8.8%
0.01%
-14.3%
Q1 2020$1,918,000
-35.4%
227,300
-33.0%
0.01%0.0%
Q4 2019$2,971,000
-17.2%
339,500
+1.9%
0.01%
-22.2%
Q3 2019$3,586,000
+32.8%
333,100
+56.8%
0.01%
+28.6%
Q2 2019$2,700,000
+827.8%
212,400
+2732.0%
0.01%
+600.0%
Q1 2019$291,000
-94.6%
7,500
-90.6%
0.00%
-93.3%
Q1 2018$5,417,000
-28.2%
79,600
+4.3%
0.02%
-25.0%
Q4 2017$7,542,000
+135.0%
76,300
+184.7%
0.02%
+122.2%
Q3 2017$3,209,000
+72.1%
26,800
+239.2%
0.01%
-35.7%
Q1 2015$1,865,000
+3.7%
7,900
-16.8%
0.01%0.0%
Q4 2014$1,798,000
+47.7%
9,500
+86.3%
0.01%
+40.0%
Q3 2014$1,217,0005,1000.01%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q2 2019
NameSharesValueWeighting ↓
Camber Capital Management LP 2,400,000$25,032,0001.43%
TANG CAPITAL MANAGEMENT LLC 1,365,376$14,241,0001.38%
Palo Alto Investors LP 1,343,897$14,017,0000.84%
Sofinnova Investments, Inc. 1,197,630$12,491,0000.79%
Gyon Technologies Capital Management, LP 29,745$310,0000.75%
RICE HALL JAMES & ASSOCIATES, LLC 455,567$4,752,0000.20%
GLOBEFLEX CAPITAL L P 63,226$659,0000.17%
PDT Partners, LLC 188,538$1,966,0000.13%
CADENCE CAPITAL MANAGEMENT LLC 71,179$742,0000.11%
FRED ALGER MANAGEMENT, LLC 2,474,029$25,804,0000.08%
View complete list of PUMA BIOTECHNOLOGY INC shareholders